The MarketWatch News Department was not involved in the development of this written content. Feb 03, 2021 (CDN Newswire through...
Highlights
SAN DIEGO, Jan. 11, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives...
Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune and blood...
BOSTON--(BUSINESS WIRE)--AVEO Oncology (Nasdaq: AVEO) today highlighted its recent progress and outlined its 2021 outlook. “We remain keenly focused on...
The MarketWatch Information Department was not associated in the generation of this content. Jan 17, 2021 (CDN Newswire through Comtex)...
For Fast Release Chicago, IL – January 18, 2021 – Zacks.com announces the checklist of shares featured in the Analyst...
CAMBRIDGE, Mass.--(Business Wire)--Magenta Therapeutics (NASDAQ: MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of immune...
Pivotal Phase III study in patients with severe dermatological condition bullous pemphigoid (BP) planned to start H1 2021 following successful...